Title: Medicinal Chemist (Retired)
Location: Creede, Colorado, United States
Charles Armon Harbert, PhD, Retired Medicinal Chemist, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in the pharmaceutical industry.
An acclaimed figure in the pharmaceutical industry, Dr. Harbert has more than 30 years of professional excellence in his areas of expertise. Retired from his position as vice president of the Groton Research Site with Pfizer, Inc., since 1999, he had climbed the ranks of success with the corporation from research scientist to project leader, manager, director, executive director, and senior executive director from 1969 to 1993. He began his career in the pharmaceutical industry as a postdoctoral fellow with the National Institutes of Health at Stanford University from 1967 to 1969.
Alongside his professional endeavors, Dr. Harbert served as co-chair of the Keystone Symposium in 1995 and was a member of the visiting committee of Connecticut College in 1986 and 1993. In addition, from 1992 to 1999, he held the role of member of the advisory committee in the department of chemistry at the University of Missouri, and in 1990, he was chair of the Medicinal Chemistry Gordon Research Conference in New London, CT.
The recipient of a Bachelor of Science from the University of Colorado and Doctor of Philosophy from the University of Missouri, Dr. Harbert is most renowned for his invention and patent of conformational mapping of a dopamine receptor for antagonists, as well as his cofounding of the popular antidepressant, Zoloft. He was formerly a member of the awards committee of the Medical Chemical Division of the American Chemical Society and Phi Lambda Upsilon.
In addition to his roles as a pharmaceutical leader, Dr. Harbert is also a prolific author, penning such historical works as “Colorado History: Insights and Views through Postcards” in 2006, “Creede, Colorado History: Insights and Views through Postcards” in 2010, and “Bachelor Colorado: History of a San Juan Mining Ghost Town” in 2017.
In recognition of his exceptional accomplishments, Dr. Harbert has been honored with several accolades throughout his career. The recipient of a Distinguished Alumni Award from the University of Missouri in 1993, he was also honored with the Team Innovation Award from the American Chemical Society for his role in the discovery of Zoloft in 2005. Furthermore, he has been selected for inclusion into several editions of Who’s Who in Finance and Business, Who’s Who in America, and Who’s Who in Science and Engineering.
Contact Dr. Harbert